Glioblastoma Clinical Trials in Lausanne
3 recruitingLausanne, Switzerland
Showing 1–3 of 3 trials
Recruiting
Phase 3
EF-41/KEYNOTE D58: Phase 3 Study of Optune Concomitant With Temozolomide Plus Pembrolizumab in Newly Diagnosed Glioblastoma
Glioblastoma
NovoCure GmbH741 enrolled82 locationsNCT06556563
Recruiting
Phase 2
Surgery for Recurrent Glioblastoma
Glioblastoma
Insel Gruppe AG, University Hospital Bern120 enrolled25 locationsNCT02394626
Recruiting
Phase 1Phase 2
A Study to Evaluate Safety and Efficacy of L19TNF Plus Lomustine in Patients With Glioblastoma at First Progression
Glioblastoma
Philogen S.p.A.142 enrolled15 locationsNCT04573192